A randomized trial of effect of elemental diet (Elental) to stomatitis and diarrhea in chemotherapy to patients with esophageal cancer

A randomized trial of effect of elemental diet (Elental) to stomatitis and diarrhea in chemotherapy to patients with esophageal cancer - A randomized trial of effect of elemental diet (Elental) to stomatitis and diarrhea in chemotherapy to patients with esophageal cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004898

Enrollment

Registered

2011-01-31

Start date

2011-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stomatitis and diarrhea in chemotherapy to patients with esophageal cancer

Interventions

Elental (Ajinomoto Pharmaceuticals Co., Ltd. Tokyo) administered orally one package daily for two weeks from the date of the start of chemotherapy No treatment group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patient with esophageal cancer in chemotherapy 2) Patient whose age is more than twenty. 3) Patient who gives written informed concent.

Exclusion criteria

Exclusion criteria: 1) Patient in radiotherapy

Design outcomes

Primary

Measure	Time frame
The grade of stomatitis and diarrhea by NCI-CTCAE ver.4.0 (1 and 2 weeks after the beginning of administration)	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026